Inogen Inc. Files 8-K on Financials

TL;DR

Inogen filed an 8-K, expect financial updates soon.

AI Summary

On August 7, 2025, Inogen Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as financial statements and exhibits. No specific financial figures or significant events were detailed in the provided excerpt.

Why It Matters

This filing indicates Inogen Inc. is providing updates on its financial performance and condition to the SEC, which is important for investors to monitor the company's health.

Risk Assessment

Risk Level: low — The provided text is a standard SEC filing notification and does not contain specific financial results or material events that would indicate a change in risk.

Key Players & Entities

• Inogen Inc. (company) — Registrant
• August 07, 2025 (date) — Date of earliest event reported
• Delaware (jurisdiction) — State of Incorporation
• 859 Ward Drive (address) — Principal Executive Offices
• Goleta, California (location) — Principal Executive Offices City and State
• 93111 (zip_code) — Principal Executive Offices Zip Code
• (805) 562-0500 (phone_number) — Registrant's Telephone Number

FAQ

Key Financial Figures

• $0.001 — nge on which registered Common Stock, $0.001 par value INGN The Nasdaq Stock Mar

Filing Documents

• ingn-20250807.htm (8-K) — 45KB
• ingn-ex99_1.htm (EX-99.1) — 870KB
• img132417817_0.jpg (GRAPHIC) — 8KB
• 0000950170-25-105080.txt ( ) — 1055KB
• ingn-20250807.xsd (EX-101.SCH) — 23KB
• ingn-20250807_htm.xml (XML) — 4KB

02. Results of Operations and Financial Condition

Item 2.02. Results of Operations and Financial Condition. On August 7, 2025, Inogen, Inc. (the "Company") issued a press release reporting its financial results for the second quarter ended June 30, 2025. A copy of the press release is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K. The information set forth under this Item 2.02, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific reference in such a filing.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit Description 99.1 Press Release dated August 7, 2025 . 104 The cover page of this Current Report on Form 8-K, formatted in Inline XBRL.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. INOGEN, INC. Date: August 7, 2025 By: /s/ Michael Bourque Michael Bourque Executive Vice President Chief Financial Officer Treasurer (Principal Accounting and Financial Officer)

View Full Filing

View this 8-K filing on SEC EDGAR